ACCELERON PHARMA INC Insider Trading for August 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for August 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 3.88 | 20,000 | 77,600 | 3,500 | |
| Aug 25 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 3.88 | 20,000 | 77,600 | 52,004 | 32 K to 52 K (+62.49 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | MCGUIRE TERRANCE | Director | Sell | S | 30.25 | 407,259 | 12,319,585 | 1,303,232 | 1.7 M to 1.3 M (-23.81 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 5.08 | 1,600 | 8,128 | 19,896 | |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 0 | |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 31.69 | 200 | 6,338 | 10,100 | 10.3 K to 10.1 K (-1.94 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 30.99 | 800 | 24,792 | 10,300 | 11.1 K to 10.3 K (-7.21 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 31.95 | 400 | 12,780 | 11,100 | 11.5 K to 11.1 K (-3.48 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 31.69 | 200 | 6,338 | 32,004 | 32.2 K to 32 K (-0.62 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 31.00 | 1,400 | 43,400 | 32,204 | 33.6 K to 32.2 K (-4.17 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 5.08 | 1,600 | 8,128 | 33,604 | 32 K to 33.6 K (+5.00 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 31.60 | 1,210 | 38,236 | 32,004 | 33.2 K to 32 K (-3.64 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Sell | S | 30.83 | 2,790 | 86,016 | 33,214 | 36 K to 33.2 K (-7.75 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | EVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 36,004 | 32 K to 36 K (+12.50 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Option Exercise | M | 5.28 | 2,000 | 10,560 | 34,307 | |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Sell | S | 30.46 | 2,000 | 60,920 | 57,656 | 59.7 K to 57.7 K (-3.35 %) |
| Aug 19 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | EVP & Chief Operati ... | Buy | M | 5.28 | 2,000 | 10,560 | 59,656 | 57.7 K to 59.7 K (+3.47 %) |
| Aug 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 3.88 | 1,039 | 4,031 | 27,500 | |
| Aug 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.88 | 4,461 | 26,231 | 0 | |
| Aug 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 31.74 | 2,200 | 69,828 | 36,123 | 38.3 K to 36.1 K (-5.74 %) |
| Aug 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 30.22 | 3,300 | 99,726 | 38,323 | 41.6 K to 38.3 K (-7.93 %) |
| Aug 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 3.88 | 1,039 | 4,031 | 41,623 | 40.6 K to 41.6 K (+2.56 %) |
| Aug 17 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.88 | 4,461 | 26,231 | 40,584 | 36.1 K to 40.6 K (+12.35 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 1,500 | 5,820 | 42,251 | |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 43,751 | |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 28.54 | 1,500 | 42,810 | 40,000 | 41.5 K to 40 K (-3.61 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 1,500 | 5,820 | 41,500 | 40 K to 41.5 K (+3.75 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 29.23 | 100 | 2,923 | 40,000 | 40.1 K to 40 K (-0.25 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 28.51 | 4,900 | 139,699 | 40,100 | 45 K to 40.1 K (-10.89 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 45,000 | 40 K to 45 K (+12.50 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 5.08 | 19,000 | 96,520 | 240,133 | |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 29.22 | 500 | 14,610 | 21,584 | 22.1 K to 21.6 K (-2.26 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 28.51 | 18,500 | 527,435 | 22,084 | 40.6 K to 22.1 K (-45.58 %) |
| Aug 12 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 5.08 | 19,000 | 96,520 | 40,584 | 21.6 K to 40.6 K (+88.03 %) |
| Aug 03 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 0.40 | 4,000 | 1,600 | 8,500 | |
| Aug 03 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 0.40 | 4,000 | 1,600 | 21,584 | 17.6 K to 21.6 K (+22.75 %) |
| Aug 03 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.28 | 5,895 | 31,126 | 6,250 | |
| Aug 03 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.28 | 7,527 | 39,743 | 2,346 | |
| Aug 03 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.28 | 5,895 | 31,126 | 36,123 | 30.2 K to 36.1 K (+19.50 %) |
| Aug 03 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.28 | 7,527 | 39,743 | 30,228 | 22.7 K to 30.2 K (+33.16 %) |